Nutritional supplements for prevention of type 2 diabetes - postprandial study

INTERVENTION: Participants will visit Nutraceuticals clinical research rooms after an overnight fast of at least 10 hours. Following arrival, study participants will be randomly allocated to a single dose of these treatment arms on four visit days before receiving a standardised meal. 1. Placebo: 4 oral capsules (2 each for matching for curcumin and matching for fish oil placebos) 2. Curcumin (2 tablets @500 mg each) providing 180 mg curcumin plus 2 placebo matching for fish oil capsule 3: Fish oil (2 capsules @1000mg each) providing 1.2g EPA/DHA plus 2 placebo matching for curcumin capsules. 4: Curcumin (2 tablets @500 mg each providing a total of 180 mg curcumin) and fish oil (2 capsules @1000mg each providing a total of 1.2g EPA/DHA) Standardised meal included: 2 toasted white bread slices, 22g of peanut spread and chocolate flavoured milk. Participants receive treatments with a washout period of one week. Tablets/Capsules will be provided to the participants by the study investigator and are consumed before investigator. Participants are advised consuming the meal within 20 minutes. CONDITION: Type 2 diabetes PRIMARY OUTCOME: Blood glucose level SECONDARY OUTCOME: Serum Insulin Serum Triglycerides INCLUSION CRITERIA: This study is suitable for you if: You are aged between 18‐45 years You have body mass index (BMI) < 30 Kg/m2